BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04016805-completion@plaintrial.com
DTSTAMP:20261028T123557Z
DTSTART;VALUE=DATE:20220522
SUMMARY:Study to Assess the Efficacy and Safety of Ublituximab and Umbralis
 ib in Participants With Chronic Lymphocytic Leukemia (CLL) Currently Treat
 ed With Ibrutinib\, Acalabrutinib or Venetoclax — estimated completion d
 ate
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT04016805
URL:https://plaintrial.com/trial/NCT04016805
END:VEVENT
END:VCALENDAR